Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CytoCor
- Development stage
- Preclinical
- Lead developer
- International Stem Cell Corporation
- Modality
- Cell Therapies, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
CytoCor is a stem cell–derived, transparent human corneal-like tissue developed by International Stem Cell Corporation as a potential regenerative medicine product for corneal transplantation and as an in vitro model for safety testing of drugs, chemicals, and consumer products.[6][8] Generated from the company’s proprietary parthenogenetic pluripotent stem cells or embryonic stem cells, CytoCor corneal tissue is engineered to recapitulate key structural, biochemical, and refractive properties of the human cornea, with the aim of providing standardized, high-volume graft material that avoids disease-transmission risks associated with donor corneas and reduces reliance on animal eyes in toxicity testing.[6][8] The program remains at the discovery and preclinical proof-of-concept stage with ongoing collaborations to evaluate tissue handling, suturability, and biocompatibility in ophthalmic models.[6][8]
- Brand names
- CytoCor
Beyond the preview
Go deeper on CytoCor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CytoCor.